ExoVectory presents at the Life Sciences Café

On May 21, our CEO Jeroen de Vrij took the stage at the Life Sciences Café at Leiden Bio Science Park, pitching ExoVectory and its vision for exosome-based delivery.

Jeroen introduced our platform to a room full of entrepreneurs, researchers, and the next generation of life science talent, showcasing how ExoVectory's technology offers an efficient, safe, and scalable solution for cell and gene therapy applications.

The great energy and inspiring conversations made it a truly memorable evening. Thank you to the Life Sciences Café team for the invitation!

Evenings like this remind us how much momentum is building around gene therapy delivery technologies. That is why we are excited to announce that ExoVectory is entering its next growth stage, focusing on bringing a unique exosome-based delivery platform, which has the potential to redefine cell and gene therapy, closer to market.

We are open to connecting with investors who share our vision. Can't wait to share more soon!

View the original LinkedIn post

Explore our exosome delivery technology or contact ExoVectory about partnerships and investment.